Basilea Pharmaceutica Ltd (BSLN)
SIX
Closed
Aug 25, 2026
Day's Range
64.2052 wk Range
44.70Overview - BSLN - Basilea Pharmaceutica Ltd
Key Statistics
Valuation
Enterprise Value
711.62M
P/E (Trailing)
‪20.57‬
P/E (Forward)
‪15.06‬
PEG Ratio
‪15.06‬
Price / Sales (TTM)
‪3.23‬
Price / Book
‪4.93‬
EV / EBITDA
‪11.68‬
Profitability
Profit Margin
‪21.17%‬
Operating Margin
‪26.89%‬
Return on Assets
‪13.68%‬
Return on Equity
‪39.45%‬
Ownership
Shares Outstanding
12.29M
Float
12.31M
Held by Insiders
‪0.62%‬
Held by Institutions
‪30.88%‬
Price stats
Beta
‪0.41‬
50-Day Avg
‪53.09‬
200-Day Avg
‪53.09‬
Dividends
Payout Ratio
‪0.00%‬
Peers - BSLN - Basilea Pharmaceutica Ltd
Peer Comparison
Compared with companies in Biotechnology listed on SIX.
- BSLNSIXBasilea Pharmaceutica Ltd811.90MMarket Cap+27.67%52-week change19.90P/E (Trailing)‪21.17%‬Profit Margin
- BIONSIXBB Biotech AG3.06BMarket Cap+42.25%52-week change2.26P/E (Trailing)‪127.31%‬Profit Margin
- BIOVSIXBioVersys AG147.36MMarket Cap+2.78%52-week change-6.50P/E (Trailing)‪-386.62%‬Profit Margin
- ADXNSIXAddex Therapeutics Ltd6.28MMarket Cap-38.65%52-week change-0.67P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - BSLN - Basilea Pharmaceutica Ltd
About
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company headquartered in Allschwil, Switzerland, founded in 2000 as a spin-off from F. Hoffmann-La Roche. With approximately 150 employees, it focuses on discovering, developing, and commercializing innovative anti-infective drugs to address severe…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
